Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Brass

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Kidney International|January 14, 2004
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal diseaseKathy E Sietsema, Antonino Amato, Sharon G Adler, et al.
Journal of Clinical Pharmacology|September 8, 2016
Time Trends in Physician Visits for Gastroesophageal Reflux Disease Before and After the Rx-to-OTC Switch of Proton Pump InhibitorsDong W Chang, Jonathan Grotts, Chi-Hong Tseng, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
Journal of Vascular Surgery|May 21, 2013
Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery diseaseEric P Brass, Leslie T Cooper, Peter Hanson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologistsHamik A Martirosyan, Eric P Brass, Rajnish Mehrotra, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matricesMichael R Yeaman, Kimberly D Gank, Arnold S Bayer, et al.
Journal of Vascular Surgery|November 29, 2011
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudicationEric P Brass, Leslie T Cooper, Roger E Morgan, et al.
Circulation Research|April 25, 2015
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery diseaseWilliam R Hiatt, Ehrin J Armstrong, Christopher J Larson, et al.
European Journal of Applied Physiology|February 21, 2007
Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial diseaseTimothy A Bauer, Eric P Brass, Thomas J Barstow, et al.
The Journal of Pediatrics|April 7, 2018
Frequency of Poison Center Exposures for Pediatric Accidental Unsupervised Ingestions of Acetaminophen after the Introduction of Flow RestrictorsEric P Brass, Kate M Reynolds, Randy I Burnham, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Kidney International|January 14, 2004
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal diseaseKathy E Sietsema, Antonino Amato, Sharon G Adler, et al.
Journal of Clinical Pharmacology|September 8, 2016
Time Trends in Physician Visits for Gastroesophageal Reflux Disease Before and After the Rx-to-OTC Switch of Proton Pump InhibitorsDong W Chang, Jonathan Grotts, Chi-Hong Tseng, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
Journal of Vascular Surgery|May 21, 2013
Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery diseaseEric P Brass, Leslie T Cooper, Peter Hanson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2004
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologistsHamik A Martirosyan, Eric P Brass, Rajnish Mehrotra, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matricesMichael R Yeaman, Kimberly D Gank, Arnold S Bayer, et al.
Journal of Vascular Surgery|November 29, 2011
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudicationEric P Brass, Leslie T Cooper, Roger E Morgan, et al.
Circulation Research|April 25, 2015
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery diseaseWilliam R Hiatt, Ehrin J Armstrong, Christopher J Larson, et al.
European Journal of Applied Physiology|February 21, 2007
Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial diseaseTimothy A Bauer, Eric P Brass, Thomas J Barstow, et al.
The Journal of Pediatrics|April 7, 2018
Frequency of Poison Center Exposures for Pediatric Accidental Unsupervised Ingestions of Acetaminophen after the Introduction of Flow RestrictorsEric P Brass, Kate M Reynolds, Randy I Burnham, et al.
Pageof 8